Genedrive Interim Loss Narrows As It Continues Focus On Hepatitis
LONDON (Alliance News) - Genedrive PLC on Thursday reported a reduction in its interim loss, as it continues to progress its hepatitis testing product.For the six months to the end of 2018, Read More